Add like
Add dislike
Add to saved papers

Human Indoleamine 2,3-Dioxygenase 1 is an Efficient Mammalian Nitrite Reductase.

Biochemistry 2018 December 27
The heme enzyme indoleamine 2,3-dioxygenase-1 (IDO1) catalyzes the first reaction of L-tryptophan oxidation along the kynurenine pathway. IDO1 is a central immunoregulatory enzyme with important implications for inflammation, infectious disease, autoimmune disorders and cancer. Here we demonstrate that IDO1 is a mammalian nitrite reductase capable of chemically reducing nitrite to nitric oxide (NO) under hypoxia. UV-visible absorption and resonance Raman spectroscopy showed that incubation of dithionite-reduced, ferrous IDO1 protein (FeII -IDO) with nitrite under anaerobic conditions resulted in the time-dependent formation of a FeII -nitrosyl IDO1 species, which was inhibited by substrate L-tryptophan, dependent on the concentration of nitrite or IDO1 and independent of the concentration of the reductant, dithionite. The bimolecular rate constant for IDO1 nitrite reductase activity was determined as 5.4 M-1 s-1 (pH 7.4, 23 C), which was comparable to that measured for myoglobin (3.6 M-1 s-1 ; pH 7.4, 23 C), an efficient and biologically important mammalian heme-based nitrite reductase. IDO1 nitrite reductase activity was pH dependent but differed with myoglobin in that it showed a reduced proton dependency at pH>7. Electron paramagnetic resonance studies measuring NO production showed that the conventional IDO1 dioxygenase reducing co-factors, ascorbate plus methylene blue, enhanced IDO1's nitrite reductase activity and the time- and IDO1 concentration-dependent release of NO in a manner inhibited by L-tryptophan or the IDO inhibitor 1-methyl-L-tryptophan. These data identify IDO1 as an efficient mammalian nitrite reductase that is capable of generating NO under anaerobic conditions. IDO1's nitrite reductase activity may have important implications for the enzyme's biological actions when expressed within hypoxic tissues.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app